Koichi Azuma

641 citations
5 papers · 12 indexed · h-index 3
Topics
Cancer Immunotherapy and Biomarkers (2 papers)Radiomics and Machine Learning in Medical Imaging (1 paper)RNA modifications and cancer (1 paper)
Partner nations
JapanUnited States

In The Last Decade

Koichi Azuma

3 papers receiving 12 citations

Peers

Koichi Azuma
Comparison fields: 5 of 9
  • Molecular Biology 7
  • Cancer Research 6
  • Pulmonary and Respiratory Medicine 5
  • Oncology 4
  • Radiology, Nuclear Medicine and Imaging 2
Replace Alejandro Acevedo with:
Alejandro Acevedo United States
Esha Banerjee United States
Nancy Roche United States
Haibo Xu China
Nils Rouven Hansmeier Germany
Andrey Semenov Russia
Ellice Marwood United Kingdom
Éva Somogyiné Ezer Hungary
Vinayak Bhandari Canada
Tifenn L’Haridon France
Koichi Azuma relative to Alejandro Acevedo United States Alejandro Acevedo's profile →
Citations per field
00.5×1.5×
Alejandro Acevedo · 1×
Citations per year

Countries citing papers authored by Koichi Azuma

Since Specialization
Citations

This map shows the geographic impact of Koichi Azuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichi Azuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichi Azuma more than expected).

Fields of papers citing papers by Koichi Azuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koichi Azuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichi Azuma. The network helps show where Koichi Azuma may publish in the future.

Co-authorship network of co-authors of Koichi Azuma

This figure shows the co-authorship network connecting the top 25 collaborators of Koichi Azuma. A scholar is included among the top collaborators of Koichi Azuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koichi Azuma. Koichi Azuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1 0
2 4
3 0
4 3
5 5

About Koichi Azuma

Koichi Azuma is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 5 papers that have together received 12 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Cancer Research (6 citations), Pulmonary and Respiratory Medicine (5 citations) and Oncology (4 citations). Koichi Azuma has collaborated with scholars based in Japan and United States. Frequent co-authors include Yoshiyasu Nakamura, Shinya Sato, Taiki Hakozaki, Isamu Okamoto, Yuka Igarashi, Junko Tanizaki, Shuji Murakami, Tetsuro Sasada, Yuta Sekino and Toshihide Yokoyama. Their work appears in journals such as Frontiers in Immunology, Journal of Thoracic Oncology and JAMA Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026